Collegium Pharma (COLL) Misses Q3 EPS by 16c

Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.46), $0.16 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• BIG3 Basketball to go public via Graf Global merger at $290 million
• Lennar Corp. (LEN) Misses Q2 EPS by 1c